healthcare

Search documents
Clover Health to Participate in Upcoming Canaccord Genuity 45th Annual Growth Conference
Globenewswire· 2025-07-21 20:05
WILMINGTON, Del., July 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, 2025, at 11:00 a.m. Eastern Time. A live webcast and replay of the presentation will be accessible from Clover Health's investor relations website at https://investors.cloverhealth.com/. About Clover Health:Clo ...
How Hims Became the King of Knockoff Weight-Loss Drug #weightloss #health #shorts
Bloomberg Television· 2025-07-21 18:27
Hims and Hers has gone from a scrappy startup best known for selling Viagra to a teleaalth powerhouse worth almost 11 billion in just a few years. In true Silicon Valley fashion, the company pivoted whenever possible to the next hot product, providing CO 19 tests during the pandemic and later online therapy and generic Prozac. In addition, its splashy, celebritybacked, and occasionally cringe-worthy ads have lured roughly 2.4% 4 million subscribers to its platform where virtual doctors prescribe popular dru ...
Will DaVita HealthCare (DVA) Beat Estimates Again in Its Next Earnings Report?
ZACKS· 2025-07-21 17:10
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? DaVita HealthCare (DVA) , which belongs to the Zacks Medical - Outpatient and Home Healthcare industry, could be a great candidate to consider.When looking at the last two reports, this kidney dialysis provider has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 7.82%, on average, in the last two quarters. ...
00后的“保命新四样”
吴晓波频道· 2025-07-21 17:05
点击上图▲立即收听 " 18—35 岁年轻人的消费榜单前三位,分别是旅游、数码产品和保健养生。 " 文 / 巴九灵(微信公众号:吴晓波频道) "舌苔偏厚,体质寒湿,肝火旺,建议少吃辛辣、冰饮。" 下午时分,26岁的白领小陈对着手机摄像头伸出舌头,屏幕那端的AI医生瞬间给出了这样的反馈。 而看似戏谑的背后,实则是一种集体性的健康觉醒。 由国家统计局等发起的《中国美好生活大调查》显示,18—35岁年轻人的消费榜单前三位分别是旅游、数码产品和保健养生。另外根据知萌咨询 在今年3月的调研数据,Z世代平均每年在健康消费上的支出达到3250.7元。 这不,最近巨头们如火如荼的闪购战,让不少人真切体验了一把奶茶自由。网络上,关于"冰箱塞满奶茶""两天九杯冲上头"的分享不胜枚举,但也 敲响了年轻人的身体警钟。 在"求医AI"前,小陈刚好收到了动态血糖仪APP弹出的"血糖飙升"警告。 公开数据显示,中国咖啡消耗量近10年内增长了167%,消费者偏好带奶、带糖、带小料的花式咖啡;奶茶消费同样也是,超8成用户一周消费2— 3次,甚至高于3次,高频消费的同时还爱搭配软欧包食用。 当这样的"甜蜜轰炸"成为日常,直接催生了一个热词——咖 ...
大厂为何扎堆卷赛博“大白”
虎嗅APP· 2025-07-19 13:48
AI卷起的财富风暴。 出品 | 虎嗅科技医疗组 作者 | 陈广晶 编辑 | 苗正卿 头图 | AI生成 以下文章来源于AGI接口 ,作者陈广晶 AGI接口 . 花样翻新的赛博"大白"( 电影《超能陆战队》中的健康助手 )正涌进患者手机。 刚过35岁的肖颖,年初在某大医院生了宝宝。出院的时候,护士再三叮嘱她下载一个APP,在这 个软件上可以挂互联网医院的号,关于母亲和婴儿的任何问题都可以在线提问。 这个APP,肖颖早就下载了,除了线上问诊、挂号、体检、档案管理,疫苗接种预约都可以在这 个软件上进行。出院后,正好赶上流感爆发,她和婴儿相继发烧,软件上的AI报告解读,健康咨 询,缓解了肖颖初为人母的焦虑。 与肖颖类似,越来越多出院患者、门诊患者在医院、医生的介绍下拥有了赛博"大白",还不止一 个。 在其背后,面向大众的医疗AI服务呈现出爆发的趋势。业界盘点的当下最热门的20大医疗AI场景 中,面向大众的"报告解读"、"智能导诊"排在前两位,远超与医疗服务关系密切的"合理用药""医 保控费"等。 覆盖看诊前轻问诊、出院后随访等内容的AI健康管理产品更是层出不穷,已经聚集了上亿用户的 互联网大厂在其中更是激战正酣,京东 ...
These Are the 2 Worst-Performing Stocks in the Dow Jones Industrial Average So Far in 2025
The Motley Fool· 2025-07-19 13:34
The Dow Jones Industrial Average (^DJI -0.32%) is up nearly 5% so far this year, with many of its best performers rising in value by 20% to 30%.But some of the index's components haven't fared so well. Two well-known stocks in the DJIA have collapsed in value through the first six months of 2025. Investors on the lookout for bargains should take a closer look.This tech giant is struggling in 2025For years, Salesforce (CRM 0.96%) has been a market darling, consistently posting double-digit growth rates. Thus ...
CNC INVESTOR NOTICE: Centene Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Prnewswire· 2025-07-19 03:00
Core Viewpoint - The Centene class action lawsuit alleges that Centene Corporation and its executives misled investors regarding the company's revenue outlook and growth potential, leading to significant financial losses for shareholders [4][5]. Group 1: Lawsuit Details - The lawsuit, titled Lunstrum v. Centene Corporation, seeks to represent purchasers of Centene securities and claims violations of the Securities Exchange Act of 1934 [1]. - Centene is accused of creating a false impression of reliable revenue projections and growth while actual enrollment rates and market morbidity were lower than anticipated [4]. - On July 1, 2025, Centene withdrew its 2025 guidance, revealing that its market growth across 22 states was lower than expected, resulting in a significant stock price drop of over 40% [5]. Group 2: Financial Impact - The preliminary analysis indicated that Centene's guidance was reduced to approximately $1.8 billion, with an adjusted diluted EPS of $2.75 [5]. - The lawsuit highlights that over two-thirds of Centene's marketplace share showed disappointing enrollment figures, contradicting the company's earlier optimistic reports [4]. Group 3: Legal Process - Investors who suffered losses can seek to become lead plaintiffs in the class action lawsuit, which allows them to represent the interests of all class members [6]. - The lead plaintiff can choose a law firm to litigate the case, and participation as a lead plaintiff does not affect the ability to share in any potential recovery [6]. Group 4: Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [7]. - The firm has a strong track record in obtaining significant recoveries in securities class action cases, including the largest recovery in history of $7.2 billion in the Enron case [7].
CNC Investors with Losses in Excess of $100K Have Opportunity to Lead Centene Corporation Securities Fraud Lawsuit
Prnewswire· 2025-07-19 00:08
Core Viewpoint - Rosen Law Firm has announced the filing of a class action lawsuit on behalf of purchasers of Centene Corporation securities between December 12, 2024, and June 30, 2025, alleging misleading statements regarding the company's financial performance and enrollment rates [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that during the Class Period, Centene's management provided investors with overly positive information regarding expected revenue guidance and adjusted diluted earnings per share (EPS) for the 2025 fiscal year [5]. - Defendants allegedly made confident statements about Centene's enrollment and morbidity rates, as well as strong retention rates in its Medicare business, while concealing material adverse facts about the true state of these metrics [5]. Group 2: Participation Information - Investors who purchased Centene common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm directly for more information [3][6]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time and being ranked No. 1 for the number of settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [4].
Treatment.com AI Engages Marketing Services Providers
Globenewswire· 2025-07-18 21:36
Core Viewpoint - Treatment.com AI Inc. has engaged two firms, 45 Degrees and Investment Publishing, to enhance its digital marketing and investor relations efforts, aiming to increase awareness and reach within the healthcare sector [1][4]. Group 1: Engagement with 45 Degrees - Treatment has contracted 45 Degrees for a six-month marketing engagement starting July 18, 2025, with a total fee of USD $180,000, payable in two installments [2]. - The marketing services include Google Ads, social media, and video interview distribution, with an option to extend the engagement on a month-to-month basis for USD $25,000 [2]. - Treatment has issued 400,000 stock options to the principal of 45 Degrees, exercisable at $0.45 per share for three years [3]. Group 2: Engagement with Investment Publishing - Treatment has engaged Investment Publishing for an initial one-year term to enhance its investor relations strategy, focusing on increasing company awareness [4]. - The engagement includes public relations efforts, educational content, and direct outreach through various digital platforms [4]. - Investment Publishing will also receive 400,000 stock options, exercisable at $0.45 per share for three years [4]. Group 3: Additional Option Grants - Treatment has granted an additional 400,000 stock options to certain arm's length consultants, also exercisable at $0.45 per share for three years [5]. Group 4: Company Overview - Treatment.com AI utilizes artificial intelligence to improve healthcare sector efficiencies, with a comprehensive AI engine known as the Global Library of Medicine (GLM) [6]. - The GLM provides over 10,000 expert medical reviews and supports healthcare professionals by reducing administrative burdens and improving patient care [6].
Molina to Report Q2 Earnings: Healthy Revenues, Weak Pulse on Earnings
ZACKS· 2025-07-18 17:05
Key Takeaways Molina's Q2 EPS is expected at $5.56, down 5.1% YoY, on $10.84B in revenues, up 9.7%. MOH faces rising costs, lower investment income, and a higher medical care ratio in the Marketplace. Q2 Medicaid membership likely dipped 1.2%, while Marketplace membership surged 63% from last year.Healthcare plan provider, Molina Healthcare, Inc. (MOH) , is set to report second-quarter 2025 results on July 23, 2025, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earn ...